GRG's Center For Experiential Learning

In hospital capital equipment decisions, progress slows not because value is unclear, but because accountability is fragmented clinical teams champion patient impact yet engineering and procurement brace for the long-term fallout of reliability failures and hidden costs. When no single group owns the downside, hesitation reigns until risks feel shared.

The development : In October 2022, Dostarlimab met its primary endpoint of Objective Response Rate (ORR) in a head-to-head trial against...